Clinical trial
A Phase II Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of J867 Administered in Patients With Endometriosis
NCT00160446 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of J867 Administered in Patients With Endometriosis
- Lead sponsor
- Abbott
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2000
- Completion date
- July 31, 2001
- Enrollment
- 130 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.